← FDA Drug Approvals (Drugs@FDA)
DASATINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2025-03-03
Drug application
- FDA Application #
ANDA217217- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DASATINIB
- Generic name
- DASATINIB
- Active ingredients
- DASATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- BIOCON PHARMA
- Manufacturer
- Biocon Pharma Inc.
- First approval
- 2025-03-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown